SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano, who will be based in the United States, brings over two decades of finance leadership experience in the medical technology and life sciences sectors. Her appointment is expected to bolster the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Romano's most recent role was CFO of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet, and support strategic objectives. She has also served as CFO for Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting, and investor relations. Her extensive experience in capital raising and financial management is expected to be instrumental as SS Innovations seeks to scale its operations and bring its robotic surgery platform to new markets.
The SSi Mantra surgical robotic system is designed to make robotic surgery more affordable and accessible worldwide. The company also offers a suite of SSi Mudra surgical instruments supporting various procedures, including cardiac surgery. With a corporate presence in both the United States and India, SS Innovations aims to expand its global footprint. The appointment of Romano comes at a critical time as the company prepares for the regulatory pathway in the U.S., a key milestone for commercial expansion.
For more details about the announcement, visit the full press release at https://ibn.fm/pAqlP. Additional information about SS Innovations and its latest news is available at https://ibn.fm/SSII.
